Sign in to view content

Safety Results of ONS-5010, an Ophthalmic Bevacizumab, in Treated Eyes of Patients With Wet AMD, DME, and BRVO

Suber S. Huang, MD, MBA, FASRS

Video
Published 2021

Related

Incidence of New Choroidal Neovascularization in Fellow Eyes of Patients Treated With Intravitreal Aflibercept or Ranibizumab in the VIEW studies
Robert L. Avery, MD
On Demand Cases, Courses, and Papers
2017
Faricimab in Neovascular Age-Related Macular Degeneration: Year 2 Efficacy, Safety, and Durability Results From the Phase 3 TENAYA and LUCERNE Trials
Arshad M. Khanani, MD, MA, FASRS
Updates from the Field
2022
Early Switch to the Dexamethasone Implant After Sub-Optimal Response to Anti-VEGF Therapy for Diabetic Macular Edema
Shawn Kavoussi, MD
Annual Meeting Talks
2021

Category: Retinal Vascular Disease

See more